Variations in abundance were calculated as the ratio of average values of %Vol between two temperatures. Only spots with a %Vol variation ratio greater than 2 (with significance set at 17-AAG cell line 2-fold change) in the ImageMaster 2D Platinum report were considered relevant. Figure 1 OM proteome analysis following cold shock in M. catarrhalis. OMPs

were extracted from a culture of M. catarrhalis strain O35E, which was exposed to a 3-hour cold shock at 26°C (A) or to continuous growth at 37°C (B). A collection of 6 gels (3 of each temperature) resulting from three independent experiments was analyzed by ImageMaster® 2D Platinum software (Amersham). Three OMPs that are differentially regulated in response to a 26°C cold shock, are indicated in the boxes (A and B). Gel of OMPs isolated from a M. catarrhalis O35E.tbpB

mutant grown at 37°C is shown (C). Identified proteins are labeled. The NU7441 price pI and mass (kDa) values are shown at the top and the right side of each gel. Treatment of M. catarrhalis with lactoferrin Treatment of M. catarrhalis with lactoferrin was performed as described elsewhere this website [26]. Strain O35E was grown to an OD600 of 0.5, resuspended in assay solution containing 0.1% gelatine to a concentration of 105 CFU/mL prior to the addition of lactoferrin (1 mg/mL, Sigma). Samples were incubated at 37°C for 1 and 3 h followed by plating on BHI agar to determine viability. Flow cytometry Bacteria were exposed to 26°C or 37°C for 3 h. The OD600 was adjusted to 0.2, the 200-μL aliquots were washed in PBS-1% BSA, and incubated with 1 μg/mL of lactoferrin SB-3CT or with 1 μg of vitronectin (Millipore) for 1 h. To assess the ability of M. catarrhalis to bind salivary lactoferrin, bacteria were preincubated with saliva samples (1:20 dilution) from healthy adults. Bacteria were incubated with mouse anti-human lactoferrin monoclonal antibody (AbD Serotec) or mouse anti-human vitronectin monoclonal antibody (Quidel) followed by incubation with Alexa 488-conjugated goat

anti-mouse antibody (Invitrogen) and analyzed on a FACScan cytometer using CellQuest software (version 4.2; BD Bioscience). Anti-human lactoferrin or vitronectin antibodies and Alexa 488-conjugated anti-mouse antibody were added separately as negative controls. Binding of transferrin to M. catarrhalis was analyzed using fluorescein isothiocyanate (FITC)-conjugated human transferrin (0.1 μg/mL, Jackson Immunoresearch). The ability of M. catarrhalis to bind human IgD was analyzed as described elsewhere [27]. Strain O35E, Hag-deficient mutant (O35E.hag), LOS-deficient mutant (O35E.lpxA) and clinical isolate 300 were exposed to 26°C or 37°C for 3 h, harvested, and incubated with 50% of pooled normal human serum (NHS) as a source of IgD, followed by a FITC-conjugated rabbit anti-human IgD polyclonal antibody (Dako). The expression of UspA1/A2 and CopB was analyzed using the uspA1/A2-specific 17C7 and the copB-specific 10F3 (1:20) mouse monoclonal antibodies.